In this retrospective chart review study, categorization of confirmed COVID-19 cases nasopharyngeal swab of RT-PCR was done into a group of patientswho received hydroxychloroquine standard dose and another control groupwho did not receive hydroxychloroquine. The main comparing parameter was to see virus clearance days across both groups.
Results:
A total of 112 patients were included for the study, and grouped of 72 patientwho received HCQS and remaining 40 patients as control. The virus clearance time in days was found to be 9.01±3.08 for HCQS group and for control group it was 8.64±2.34 days (Man Whitney U test value = 2.13, p=0.756).
Conclusions:
There is no significant difference found in attaining virus negative status with use of HCQS administration in this study.